Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Natural history and clinical response: "it's the virus, stupid, or is it the host?".

Nucara S, Caroleo B, Guadagnino V, Perrotti N, Trapasso F.

BMC Infect Dis. 2012;12 Suppl 2:S6. doi: 10.1186/1471-2334-12-S2-S6. Epub 2012 Nov 12. Review.

2.

IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.

Rao HY, Sun DG, Jiang D, Yang RF, Guo F, Wang JH, Liu F, Zhang HY, Zhang HH, Du SC, Jin Q, Qin H, Lok AS, Wei L.

J Viral Hepat. 2012 Mar;19(3):173-81. doi: 10.1111/j.1365-2893.2011.01497.x. Epub 2011 Aug 4.

PMID:
22329371
3.

IL28B genomic-based treatment paradigms for patients with chronic hepatitis C infection: the future of personalized HCV therapies.

Clark PJ, Thompson AJ, McHutchison JG.

Am J Gastroenterol. 2011 Jan;106(1):38-45. doi: 10.1038/ajg.2010.370. Epub 2010 Oct 5. Review.

PMID:
20924369
4.

Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactions.

Chinnaswamy S.

J Interferon Cytokine Res. 2014 Jul;34(7):479-97. doi: 10.1089/jir.2013.0113. Epub 2014 Feb 20. Review.

5.

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.

Bochud PY, Bibert S, Kutalik Z, Patin E, Guergnon J, Nalpas B, Goossens N, Kuske L, Müllhaupt B, Gerlach T, Heim MH, Moradpour D, Cerny A, Malinverni R, Regenass S, Dollenmaier G, Hirsch H, Martinetti G, Gorgiewski M, Bourlière M, Poynard T, Theodorou I, Abel L, Pol S, Dufour JF, Negro F; Swiss Hepatitis C Cohort Study Group; ANRS HC EP 26 Genoscan Study Group.

Hepatology. 2012 Feb;55(2):384-94. doi: 10.1002/hep.24678. Epub 2011 Dec 16.

PMID:
22180014
6.

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.

Suppiah V, Gaudieri S, Armstrong NJ, O'Connor KS, Berg T, Weltman M, Abate ML, Spengler U, Bassendine M, Dore GJ, Irving WL, Powell E, Hellard M, Riordan S, Matthews G, Sheridan D, Nattermann J, Smedile A, Müller T, Hammond E, Dunn D, Negro F, Bochud PY, Mallal S, Ahlenstiel G, Stewart GJ, George J, Booth DR; International Hepatitis C Genetics Consortium (IHCGC).

PLoS Med. 2011 Sep;8(9):e1001092. doi: 10.1371/journal.pmed.1001092. Epub 2011 Sep 13.

7.

The impact of human gene polymorphisms on HCV infection and disease outcome.

Schaefer EA, Chung RT.

Semin Liver Dis. 2011 Nov;31(4):375-86. doi: 10.1055/s-0031-1297926. Epub 2011 Dec 21. Review.

PMID:
22189977
8.

Host genomics and HCV treatment response.

Clark PJ, Thompson AJ.

J Gastroenterol Hepatol. 2012 Feb;27(2):212-22. doi: 10.1111/j.1440-1746.2011.06918.x. Review.

PMID:
21916985
9.

Genomics and HCV infection: progression of fibrosis and treatment response.

Estrabaud E, Vidaud M, Marcellin P, Asselah T.

J Hepatol. 2012 Nov;57(5):1110-25. doi: 10.1016/j.jhep.2012.05.016. Epub 2012 May 30. Review.

10.

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes.

Montes-Cano MA, García-Lozano JR, Abad-Molina C, Romero-Gómez M, Barroso N, Aguilar-Reina J, Núñez-Roldán A, González-Escribano MF.

Hepatology. 2010 Jul;52(1):33-7. doi: 10.1002/hep.23624.

PMID:
20578254
11.

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors.

Kurosaki M, Tanaka Y, Nishida N, Sakamoto N, Enomoto N, Honda M, Sugiyama M, Matsuura K, Sugauchi F, Asahina Y, Nakagawa M, Watanabe M, Sakamoto M, Maekawa S, Sakai A, Kaneko S, Ito K, Masaki N, Tokunaga K, Izumi N, Mizokami M.

J Hepatol. 2011 Mar;54(3):439-48. doi: 10.1016/j.jhep.2010.07.037. Epub 2010 Sep 19.

PMID:
21129805
12.

A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.

Halfon P, Bourliere M, Ouzan D, Maor Y, Renou C, Wartelle C, Pénaranda G, Tran A, Botta D, Oules V, Castellani P, Portal I, Argiro L, Dessein A.

Eur J Gastroenterol Hepatol. 2011 Oct;23(10):931-5. doi: 10.1097/MEG.0b013e328349d0ef.

PMID:
21900787
13.

IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.

Di Marco V, Bronte F, Calvaruso V, Capra M, Borsellino Z, Maggio A, Renda MC, Pitrolo L, Lo Pinto MC, Rizzo M, Fiorenza F, Gerardi C, Grimaudo S, Di Cristina A, Levrero M, Craxì A.

Haematologica. 2012 May;97(5):679-86. doi: 10.3324/haematol.2011.050351. Epub 2011 Dec 16.

14.

Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection.

Marabita F, Aghemo A, De Nicola S, Rumi MG, Cheroni C, Scavelli R, Crimi M, Soffredini R, Abrignani S, De Francesco R, Colombo M.

Hepatology. 2011 Oct;54(4):1127-34. doi: 10.1002/hep.24503. Epub 2011 Aug 19.

PMID:
21721028
15.

[Genetics and hepatitis C treatment: towards a personalized treatment?].

Lens García S, Coto-Llerena M, Pérez del Pulgar Gallart S, Forns Bernhardt X.

Gastroenterol Hepatol. 2011 May;34(5):352-60. doi: 10.1016/j.gastrohep.2010.12.008. Epub 2011 Mar 21. Review. Spanish.

PMID:
21420759
16.

Simultaneous genotyping of rs12979860 and rs8099917 variants near the IL28B locus associated with HCV clearance and treatment response.

Melis R, Fauron C, McMillin G, Lyon E, Shirts B, Hubley LM, Slev PR.

J Mol Diagn. 2011 Jul;13(4):446-51. doi: 10.1016/j.jmoldx.2011.03.008. Epub 2011 May 14.

17.

A tetra-primer amplification refractory mutation system polymerase chain reaction for the evaluation of rs12979860 IL28B genotype.

Galmozzi E, Del Menico B, Rametta R, Dongiovanni P, Fracanzani AL, Benedan L, Borroni V, Maggioni P, Fargion S, Valenti L.

J Viral Hepat. 2011 Sep;18(9):628-30. doi: 10.1111/j.1365-2893.2010.01349.x. Epub 2010 Jul 26.

PMID:
20659305
18.

Host genetics.

Macías J, Vispo E, Pineda JA, Soriano V.

Curr Opin HIV AIDS. 2011 Nov;6(6):491-500. doi: 10.1097/COH.0b013e32834bca2d. Review.

PMID:
21918436
19.

Transmission of hepatitis C virus: self-limiting hepatitis or chronic hepatitis?

Saito T, Ueno Y.

World J Gastroenterol. 2013 Nov 7;19(41):6957-61. doi: 10.3748/wjg.v19.i41.6957. Review.

20.

Reply to: "Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling".

Howell CD, Jin R, Dowling TC.

J Hepatol. 2013 Apr;58(4):842-3. doi: 10.1016/j.jhep.2012.12.004. Epub 2012 Dec 11. No abstract available.

Supplemental Content

Support Center